Refine
Year of publication
- 2016 (84) (remove)
Document Type
- Article (49)
- Doctoral Thesis (19)
- Postprint (7)
- Other (5)
- Review (4)
Is part of the Bibliography
- yes (84)
Keywords
- carotenoids (4)
- Dexamethasone (3)
- Epigenetics (3)
- Manganese (3)
- metabolic syndrome (3)
- protein (3)
- Caenorhabitis elegans (2)
- Chrysopidae (2)
- Geschmack (2)
- LC-MS/MS (2)
- Solanaceae (2)
- binding (2)
- biological pest control (2)
- c. elegans (2)
- cells (2)
- chronic kidney disease (2)
- disease (2)
- force-field (2)
- hsp-70 (2)
- inflammation (2)
- insulin (2)
- life-span (2)
- menadione (2)
- multiple-pest infestation (2)
- n-acetyl-cysteine (2)
- pink1 (2)
- plant volatiles (2)
- s-glutathionylation (2)
- taste (2)
- tritrophic system (2)
- type 2 diabetes (2)
- (9Z)-neoxanthin (1)
- 5-gliadin (1)
- 6-Shogaol (1)
- 6-shogaol (1)
- Allergenic food (1)
- Allicin (1)
- Amylase (1)
- Antibiotics (1)
- Apple polyphenoloxidase (1)
- Arsenic (1)
- Baked products (1)
- Barriere (1)
- Beta-lactoglobulin (1)
- Biocompatibility (1)
- Biomarker (1)
- Bioreactor (1)
- Bittergeschmack (1)
- Bittergeschmacksrezeptoren (1)
- Blood pressure (1)
- Brassica oleracea var. sabellica (1)
- Brood size (1)
- CD, DLS (1)
- Caenorhabditis elegans (1)
- Cellular bioavailability (1)
- Cellular damage response (1)
- Chaperone (1)
- Clostridium difficile (1)
- Colonic microbiota (1)
- Covalent modification (1)
- DAF-16 transcription factor (1)
- DNMT1 (1)
- DPP-4 inhibition (1)
- Darmerkrankung (1)
- Decontamination (1)
- Delinquency (1)
- Demographic transitions (1)
- Dendritic core-multishell nanocarriers (1)
- Dermal drug delivery (1)
- Developmental programming (1)
- Diallyl disulfide (1)
- Dichlorofluorescein assay (1)
- Drug delivery systems (1)
- Edible insects (1)
- Electron paramagnetic resonance spectroscopy (1)
- Ellagsäure (1)
- Endothelin-1 transgenic mice (1)
- Enteric polymer (1)
- Entzündung (1)
- Enzyme (1)
- Ernährung (1)
- Erosion kinetics (1)
- Eudragit L 100 (1)
- Europe (1)
- Experimental autoimmune encephalomyelitis (EAE) (1)
- FISH (1)
- Fatty acid hydroperoxides (1)
- Fetal programming (1)
- Fettsäuren (1)
- Fettwahrnehmung (1)
- Food labeling (1)
- Foxp3 (1)
- Free radicals (1)
- Fruits (1)
- Functionality (1)
- G-Protein gekoppelte Rezeptoren (1)
- G-protein coupled receptors (1)
- GADD45A and GADD45G (1)
- Garlic (1)
- Genotoxicity (1)
- Gestational diabetes (1)
- Global DNA methylation (1)
- Glutathione (1)
- HPLC (1)
- HSP70 (1)
- HaCaT cells (1)
- Heart weight (1)
- Heat shock proteins (1)
- Hepatic stellate cells (1)
- Hepatocytes (1)
- Heritabilität (1)
- Hochfettdiät (1)
- Hypermethylation (1)
- ICP-QQQ-MS (1)
- IgE (1)
- In vitro blood-brain barrier model (1)
- Inactivation (1)
- Inflammatory skin disease (1)
- Inorganic mercury (1)
- Insulin (1)
- Insulin resistance (1)
- Insulinresistenz (1)
- Intergenerational effects (1)
- Ischemia/reperfusion (1)
- Kachexie (1)
- Kidney weight (1)
- LC-MS (1)
- LC/MS/MS (1)
- LC/MS/MS; Quantification of allergenic plant traces (1)
- Leber (1)
- Lipase (1)
- Lipasen (1)
- Lipidomics (1)
- Liver fibrosis (1)
- Liver injury (1)
- Long-term cellular toxicity (1)
- Makrophagen (1)
- Mass spectrometry (1)
- Maus (1)
- Mercuric mercury (1)
- Metabolism (1)
- Metabolomics (1)
- Methylmercury (1)
- MicroRNAs (1)
- Microdialysis (1)
- Mixed lymphocyte culture (MLC) (1)
- Mycobacterium tuberculosis (1)
- Myrrhe (1)
- Neurone (1)
- Nutrition (1)
- Offending (1)
- Organic mercury (1)
- Oxidative stress (1)
- PCaaC38:6 (1)
- Palmitate (1)
- Parenthood (1)
- Paternal, maternal, sex differences (1)
- Peroxidatic and resolving cysteine (1)
- Peroxiredoxin (1)
- Peroxynitrite (1)
- Pharmacokinetics (1)
- Phenol-amino-adducts (1)
- Placenta (1)
- Plant allergen (soy, sesame, lupine) (1)
- Polymeric nanoparticles (1)
- Post-translational protein modification (1)
- Postharvest processing (1)
- Preterm birth (1)
- Proteasome (1)
- Protein functionality and modification (1)
- Protein oxidation (1)
- RBP4 (1)
- Regulatory T cells (Treg) (1)
- SCFA (1)
- Saccharomyces boulardii (1)
- Selenosugar 1 (1)
- Sensorik (1)
- Skin barrier disruption (1)
- Skin model (1)
- Skin nanocarrier (1)
- Skin penetration (1)
- Small selenium species (1)
- Speciation (1)
- Sphingolipids (1)
- Sphingosine 1-phosphate (1)
- Sphingosine kinase (1)
- Tas2r (1)
- Tas2rs (1)
- Technical enzymes (1)
- Th17 (1)
- Thermal and nonthermal treatment (1)
- Thio-arsenosugar-glycerol (1)
- Thio-dimethylarsinic acid (1)
- Thiol (1)
- Thiol-dependent peroxidase (1)
- Thiomersal (1)
- Thioredoxin (1)
- Thrifty phenotype (1)
- Tight Junction (1)
- Toxicity (1)
- Toxicokinetics (1)
- Transplantation (1)
- Twister (TM) (1)
- Twister TM (1)
- Typ-2-Diabetes (1)
- Urine excretion (1)
- Verhaltensstudien (1)
- Very low birth weight infant (1)
- Vitamin A supplementation (1)
- Vitellogenin (1)
- Xylanase (1)
- Zinc (1)
- Zwillingsstudie (1)
- absorption (1)
- acid sphingomyelinase (1)
- adipogenesis (1)
- adipose tissue dysregulation (1)
- age (1)
- albuminuria (1)
- alpha-SMA (1)
- angiotensin receptor blockers (1)
- antioxidants (1)
- barrier (1)
- behavioral experiments (1)
- beta-carotene (1)
- bile acids (1)
- bioavailability (1)
- bitter taste (1)
- bitter taste receptors (1)
- breast cancer (1)
- cachexia (1)
- caquexia (1)
- cardiometabolic diseases (1)
- cell wall deficient mutant (1)
- central nervous system (1)
- ceramide (1)
- colorectal cancer (1)
- cytokines (1)
- diabetes (1)
- diet (1)
- diurnal rhythm (1)
- drug design (1)
- drug metabolism (1)
- eNOS (1)
- egg yolk (1)
- ellagic acid (1)
- energy harvest (1)
- enzymes (1)
- epidemiology (1)
- epigenetics (1)
- expression analysis (1)
- extinction (1)
- fat perception (1)
- fatty acids (1)
- fatty liver (1)
- fígado (1)
- heat shock proteins (1)
- heritability (1)
- high fat diet (1)
- high protein diet (1)
- hippocampus (1)
- iCheck (1)
- immunoblot (1)
- inflamação (1)
- insulin resistance (1)
- insulina (1)
- intesinal disease (1)
- intestinal microbiota (1)
- linear gemischte Modelle (1)
- linear mixed models (1)
- lipases (1)
- lipidomics (1)
- liver (1)
- liver metabolism (1)
- low temperature (1)
- low-grade inflammation (1)
- lutein (1)
- lycopene (1)
- macrophage (1)
- macrophages (1)
- macrófagos (1)
- malnutrition (1)
- matrix metalloproteinases (1)
- metabolic disorders (1)
- metabolisches Syndrom (1)
- metabolism (1)
- metabolomics (1)
- microRNAs (1)
- micronutrient (1)
- molecular dynamics (1)
- molecular modeling (1)
- mouse (1)
- myrrh (1)
- neuron (1)
- nonlinear microscopy (1)
- nutrition (1)
- obesity (1)
- offspring (1)
- operant behavior (1)
- orphan crops (1)
- oxidative stress (1)
- pH-sensitive nanoparticles (1)
- paternal programming (1)
- peripheral nervous system (1)
- peripheres Nervensystem (1)
- photosynthesis (1)
- plasma (1)
- prostate cancer (1)
- protein pattern (1)
- proteinuria (1)
- proteomic analysis (1)
- qPCR-based gene expression screening (1)
- quantitativ (1)
- quantitative (1)
- resistência à insulina (1)
- retinol (1)
- sensory analysis (1)
- single-cell analysis (1)
- spermatogenesis (1)
- sphingomyelin (1)
- sulfotransferase (1)
- síndrome metabólica (1)
- tight junction (1)
- tocopherol (1)
- tocopherols (1)
- transgenerational effects (1)
- twin study (1)
- underutilized species (1)
- vascular calcification (1)
- vascular smooth muscle cells (1)
- vegetables (1)
- wheat (1)
- zeaxanthin (1)
- zentrales Nervensystem (1)
Institute
- Institut für Ernährungswissenschaft (84) (remove)
Dipeptidyl peptidase (DPP)-4 inhibitors delay chronic kidney disease (CKD) progression in experimental diabetic nephropathy in a glucose-independent manner. Here we compared the effects of the DPP-4 inhibitor linagliptin versus telmisartan in preventing CKD progression in non-diabetic rats with 5/6 nephrectomy. Animals were allocated to 1 of 4 groups: sham operated plus placebo; 5/6 nephrectomy plus placebo; 5/6 nephrectomy plus linagliptin; and 5/6 nephrectomy plus telmisartan. Interstitial fibrosis was significantly decreased by 48% with linagliptin but a non-significant 24% with telmisartan versus placebo. The urine albumin-to-creatinine ratio was significantly decreased by 66% with linagliptin and 92% with telmisartan versus placebo. Blood pressure was significantly lowered by telmisartan, but it was not affected by linagliptin. As shown by mass spectrometry, the number of altered peptide signals for linagliptin in plasma was 552 and 320 in the kidney. For telmisartan, there were 108 peptide changes in plasma and 363 in the kidney versus placebo. Linagliptin up-regulated peptides derived from collagen type I, apolipoprotein C1, and heterogeneous nuclear ribonucleoproteins A2/B1, a potential downstream target of atrial natriuretic peptide, whereas telmisartan up-regulated angiotensin II. A second study was conducted to confirm these findings in 5/6 nephrectomy wild-type and genetically deficient DPP-4 rats treated with linagliptin or placebo. Linagliptin therapy in wild-type rats was as effective as DPP-4 genetic deficiency in terms of albuminuria reduction. Thus, linagliptin showed comparable efficacy to telmisartan in preventing CKD progression in non-diabetic rats with 5/6 nephrectomy. However, the underlying pathways seem to be different. Copyright (C) 2016, International Society of Nephrology. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Sphingolipids are major components of the plasma membrane. In particular, ceramide serves as an essential building hub for complex sphingolipids, but also as an organizer of membrane domains segregating receptors and signalosomes. Sphingomyelin breakdown as a result of sphingomyelinase activation after ligation of a variety of receptors is the predominant source of ceramides released at the plasma membrane. This especially applies to T lymphocytes where formation of ceramide-enriched membrane microdomains modulates TCR signaling. Because ceramide release and redistribution occur very rapidly in response to receptor ligation, novel tools to further study these processes in living T cells are urgently needed. To meet this demand, we synthesized nontoxic, azido-functionalized ceramides allowing for bio-orthogonal click-reactions to fluorescently label incorporated ceramides, and thus investigate formation of ceramide-enriched domains. Azido-functionalized C-6-ceramides were incorporated into and localized within plasma membrane microdomains and proximal vesicles in T cells. They segregated into clusters after TCR, and especially CD28 ligation, indicating efficient sorting into plasma membrane domains associated with T cell activation; this was abolished upon sphingomyelinase inhibition. Importantly, T cell activation was not abrogated upon incorporation of the compound, which was efficiently excluded from the immune synapse center as has previously been seen in Ab-based studies using fixed cells. Therefore, the functionalized ceramides are novel, highly potent tools to study the subcellular redistribution of ceramides in the course of T cell activation. Moreover, they will certainly also be generally applicable to studies addressing rapid stimulation-mediated ceramide release in living cells.
Reward-dependent instrumental behavior must continuously be re-adjusted according to environmental conditions. Failure to adapt to changes in reward contingencies may incur psychiatric disorders like anxiety and depression. When an expected reward is omitted, behavior undergoes extinction. While extinction involves active re-learning, it is also accompanied by emotional behaviors indicative of frustration, anxiety, and despair (extinction-induced depression). Here, we report evidence for a sphingolipid mechanism in the extinction of behavior. Rapid extinction, indicating efficient re-learning, coincided with a decrease in the activity of the enzyme acid sphingomyelinase (ASM), which catalyzes turnover of sphingomyelin to ceramide, in the dorsal hippocampus of rats. The stronger the decline in ASM activity, the more rapid was the extinction. Sphingolipid-focused lipidomic analysis showed that this results in a decline of local ceramide species in the dorsal hippocampus. Ceramides shape the fluidity of lipid rafts in synaptic membranes and by that way can control neural plasticity. We also found that aging modifies activity of enzymes and ceramide levels in selective brain regions. Aging also changed how the chronic treatment with corticosterone (stress) or intranasal dopamine modified regional enzyme activity and ceramide levels, coinciding with rate of extinction. These data provide first evidence for a functional ASM-ceramide pathway in the brain involved in the extinction of learned behavior. This finding extends the known cellular mechanisms underlying behavioral plasticity to a new class of membrane-located molecules, the sphingolipids, and their regulatory enzymes, and may offer new treatment targets for extinction- and learning-related psychopathological conditions.
The matrix metalloproteinases (MMP) MMP-2 and MMP-9 are physiological regulators of vascular remodelling. Their dysregulation could contribute to vascular calcification. We examined the role of the MMP-2 and MMP-9 in uraemic vascular calcification in vivo and in vitro. The impact of pharmacological MMP inhibition on the development of media calcifications was explored in an aggressive animal model of uraemic calcification. In addition, the selective effects of addition and inhibition, respectively, of MMP-2 and MMP-9 on calcium-/phosphate-induced calcifications were studied in a murine cell line of vascular smooth muscle cells (VSMCs). High-dose calcitriol treatment of uraemic rats given a high phosphate diet induced massive calcifications, apoptosis and increased gene expressions of MMP-2, MMP-9 and of osteogenic transcription factors and proteins in aortic VSMC. The MMP inhibitor doxycycline prevented the VSMC transdifferentiation to osteoblastic cells, suppressed transcription of mediators of matrix remodelling and almost completely blocked aortic calcifications while further increasing apoptosis. Similarly, specific inhibitors of either MMP-2 or -9, or of both gelatinases (Ro28-2653) and a selective knockdown of MMP-2/-9 mRNA expression blocked calcification of murine VSMC induced by calcification medium (CM). In contrast to MMP inhibition, recombinant MMP-2 or MMP-9 enhanced CM-induced calcifications and the secretion of gelatinases. These data indicate that both gelatinases provide essential signals for phenotypic VSMC conversion, matrix remodelling and the initiation of vascular calcification. Their inhibition seems a promising strategy in the prevention of vascular calcifications.
Arsenic-containing lipids (arsenolipids) are natural products of marine organisms such as fish, invertebrates, and algae, many of which are important seafoods. A major group of arsenolipids, namely, the arsenic-containing hydrocarbons (AsHC), have recently been shown to be cytotoxic to human liver and bladder cells, a result that has stimulated interest in the chemistry and toxicology of these compounds. In this study, elemental laser ablation-inductively coupled plasma mass spectrometry (LA-ICPMS) and molecular matrix-assisted laser desorption/ionization (MALDI-)MS were used to image and quantify the uptake of an AsHC in the model organism Drosophila melanogaster. Using these two complementary methods, both an enrichment of arsenic and the presence of the AsHC in the brain were revealed, indicating that the intact arsenolipid had crossed the blood-brain barrier. Simultaneous acquisition of quantitative elemental concentrations and molecular distributions could allow new insight into organ-specific enrichment and possible transportation processes of arsenic-containing bioactive compounds in living organisms.
Overweight and obesity are associated with hyperinsulinemia, insulin resistance, and a low-grade inflammation. Although hyperinsulinemia is generally thought to result from an attempt of the beta-cell to compensate for insulin resistance, there is evidence that hyperinsulinaemia itself may contribute to the development of insulin resistance and possibly the low-grade inflammation. To test this hypothesis, U937 macrophages were exposed to insulin. In these cells, insulin induced expression of the proinflammatory cytokines IL-1 beta, IL-8, CCL2, and OSM. The insulin-elicited induction of IL-1 beta was independent of the presence of endotoxin and most likely mediated by an insulin-dependent activation of NF-kappa B. Supernatants of the insulin-treated U937 macrophages rendered primary cultures of rat hepatocytes insulin resistant; they attenuated the insulin-dependent induction of glucokinase by 50%. The cytokines contained in the supernatants of insulin-treated U937 macrophages activated ERK1/2 and IKK beta, resulting in an inhibitory serine phosphorylation of the insulin receptor substrate. In addition, STAT3 was activated and SOCS3 induced, further contributing to the interruption of the insulin receptor signal chain in hepatocytes. These results indicate that hyperinsulinemia per se might contribute to the low-grade inflammation prevailing in overweight and obese patients and thereby promote the development of insulin resistance particularly in the liver, because the insulin concentration in the portal circulation is much higher than in all other tissues.
In this article, we examined to what extent parental offending influences the timing of entry into parenthood of children. Based on a literature review, we hypothesized that children of delinquent parents would be more likely to enter into parenthood at a relatively young age, and that part of that association could be explained by differences between children of delinquent and non-delinquent parents in the timing of entry into marriage and in their own delinquent behaviour. Using data from a five-generation study of high risk families in the Netherlands, we found that parental delinquency increases the chance of early childbearing among daughters, but not among sons. Among sons, parental delinquency increased son's delinquency, suggesting that parental delinquency has different consequences for the life courses of their sons and daughters.
Background: Gestational diabetes mellitus (GDM) is associated with adverse pregnancy outcomes. It is known that GDM is associated with an altered placental function and changes in placental gene regulation. More recent studies demonstrated an involvement of epigenetic mechanisms. So far, the focus regarding placental epigenetic changes in GDM was set on gene-specific DNA methylation analyses. Studies that robustly investigated placental global DNA methylation are lacking. However, several studies showed that tissue-specific alterations in global DNA methylation are independently associated with type 2 diabetes. Thus, the aim of this study was to characterize global placental DNA methylation by robustly measuring placental DNA 5-methylcytosine (5mC) content and to examine whether differences in placental global DNA methylation are associated with GDM. Methods: Global DNA methylation was quantified by the current gold standard method, LC-MS/MS. In total, 1030 placental samples were analyzed in this single-center birth cohort study. Results: Mothers with GDM displayed a significantly increased global placental DNA methylation (3.22 +/- 0.63 vs. 3.00 +/- 0.46 %; p = 0.013; +/- SD). Bivariate logistic regression showed a highly significant positive correlation between global placental DNA methylation and the presence of GDM (p = 0.0009). Quintile stratification according to placental DNA 5mC levels revealed that the frequency of GDM was evenly distributed in quintiles 1-4 (2.9-5.3 %), whereas the frequency in the fifth quintile was significantly higher (10.7 %; p = 0.003). Bivariate logistic models adjusted for maternal age, BMI, ethnicity, recurrent miscarriages, and familiar diabetes predisposition clearly demonstrated an independent association between global placental DNA hypermethylation and GDM. Furthermore, an ANCOVA model considering known predictors of DNA methylation substantiated an independent association between GDM and placental DNA methylation. Conclusions: This is the first study that employed a robust quantitative assessment of placental global DNA methylation in over a thousand placental samples. The study provides large scale evidence that placental global DNA hypermethylation is associated with GDM, independent of established risk factors.
White adipose tissue (WAT) is actively involved in the regulation of whole-body energy homeostasis via storage/ release of lipids and adipokine secretion. Current research links WAT dysfunction to the development of metabolic syndrome (MetS) and type 2 diabetes (T2D). The expansion of WAT during oversupply of nutrients prevents ectopic fat accumulation and requires proper preadipocyte-to-adipocyte differentiation. An assumed link between excess levels of reactive oxygen species (ROS), WAT dysfunction and T2D has been discussed controversially. While oxidative stress conditions have conclusively been detected in WAT of T2D patients and related animal models, clinical trials with antioxidants failed to prevent T2D or to improve glucose homeostasis. Furthermore, animal studies yielded inconsistent results regarding the role of oxidative stress in the development of diabetes. Here, we discuss the contribution of ROS to the (patho) physiology of adipocyte function and differentiation, with particular emphasis on sources and nutritional modulators of adipocyte ROS and their functions in signaling mechanisms controlling adipogenesis and functions of mature fat cells. We propose a concept of ROS balance that is required for normal functioning of WAT. We explain how both excessive and diminished levels of ROS, e. g. resulting from over supplementation with antioxidants, contribute to WAT dysfunction and subsequently insulin resistance.